Orchid Isla is a reit-mortgage business based in the US. Orchid Isla shares (ORC) are listed on the NYSE and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $2.93 |
|---|---|
| 52-week range | $2.40 - $4.49 |
| 50-day moving average | $2.94 |
| 200-day moving average | $3.91 |
| Wall St. target price | $3.88 |
| PE ratio | N/A |
| Dividend yield | $0.74 (18.43%) |
| Earnings per share (TTM) | $-1.28 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.93 from 2022-07-01
| 1 week (2022-06-28) | 0.69% |
|---|---|
| 1 month (2022-06-02) | N/A |
| 3 months (2022-04-05) | -7.28% |
| 6 months (2022-01-06) | -36.44% |
| 1 year (2021-07-06) | -43.33% |
|---|---|
| 2 years (2020-07-06) | -35.60% |
| 3 years (2019-07-05) | 6.35 |
| 5 years (2017-07-05) | 10.05 |
| Operating margin TTM | 109.81% |
|---|---|
| Gross profit TTM | $-52,616,000 |
| Return on assets TTM | -3.64% |
| Return on equity TTM | -34.79% |
| Profit margin | 0% |
| Book value | $3.35 |
| Market capitalisation | $519 million |
TTM: trailing 12 months
Dividend payout ratio: 20.32% of net profits
Recently Orchid Isla has paid out, on average, around 20.32% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 18.43% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Orchid Isla shareholders could enjoy a 18.43% return on their shares, in the form of dividend payments. In Orchid Isla's case, that would currently equate to about $0.74 per share.
While Orchid Isla's payout ratio might seem low, this can signify that Orchid Isla is investing more in its future growth.
Orchid Isla's most recent dividend payout was on 26 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2022 (the "ex-dividend date").
Over the last 12 months, Orchid Isla's shares have ranged in value from as little as $2.4022 up to $4.4853. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Orchid Isla's is 1.3199. This would suggest that Orchid Isla's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Orchid Island Capital, Inc. , a specialty finance company, invests in residential mortgage-backed securities (RMBS) in the United States. The company's RMBS is backed by single-family residential mortgage loans, referred as Agency RMBS. Its portfolio includes traditional pass-through Agency RMBS, such as mortgage pass through certificates and collateralized mortgage obligations; and structured Agency RMBS comprising interest only securities, inverse interest only securities, and principal only securities. The company qualifies as a real estate investment trust for federal income tax purposes. Orchid Island Capital, Inc. was incorporated in 2010 and is based in Vero Beach, Florida.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.